Article
Corneal cell therapy: with iPSCs, it is no more a far-sight
25 Oct 2018
Abstract excerpt
Human-induced pluripotent stem cells (hiPSCs) provide a personalized approach to study conditions and diseases including those of the eye that lack appropriate animal models to facilitate the development of novel therapeutics. Corneal disease is one of the most common causes of blindness. Hence, significant efforts are made to develop novel therapeutic approaches including stem cell-derived strategies to replace...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
